- Home
- INZY vs MED Comparison
INZY vs MED Comparison
Compare INZY & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- MED
- Stock Information
- Founded
- INZY 2015
- MED 1980
- Country
- INZY United States
- MED United States
- Employees
- INZY N/A
- MED N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- MED Packaged Foods
- Sector
- INZY Health Care
- MED Consumer Staples
- Exchange
- INZY Nasdaq
- MED Nasdaq
- Market Cap
- INZY 256.3M
- MED 152.3M
- IPO Year
- INZY 2020
- MED N/A
- Fundamental
- Price
- INZY N/A
- MED $14.58
- Analyst Decision
- INZY Buy
- MED Hold
- Analyst Count
- INZY 9
- MED 1
- Target Price
- INZY $15.22
- MED $16.50
- AVG Volume (30 Days)
- INZY 989.2K
- MED 279.2K
- Earning Date
- INZY 08-05-2025
- MED 08-04-2025
- Dividend Yield
- INZY N/A
- MED N/A
- EPS Growth
- INZY N/A
- MED N/A
- EPS
- INZY N/A
- MED N/A
- Revenue
- INZY N/A
- MED $543,452,000.00
- Revenue This Year
- INZY N/A
- MED N/A
- Revenue Next Year
- INZY N/A
- MED N/A
- P/E Ratio
- INZY N/A
- MED N/A
- Revenue Growth
- INZY N/A
- MED N/A
- 52 Week Low
- INZY $0.72
- MED $11.57
- 52 Week High
- INZY $6.24
- MED $22.66
- Technical
- Relative Strength Index (RSI)
- INZY 82.67
- MED 60.09
- Support Level
- INZY $3.94
- MED $12.95
- Resistance Level
- INZY $3.97
- MED $14.90
- Average True Range (ATR)
- INZY 0.01
- MED 0.67
- MACD
- INZY -0.08
- MED 0.12
- Stochastic Oscillator
- INZY 100.00
- MED 83.98
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.